JP2001057895A - Extraction of 3-hydroxyalkanoic acid - Google Patents

Extraction of 3-hydroxyalkanoic acid

Info

Publication number
JP2001057895A
JP2001057895A JP11233656A JP23365699A JP2001057895A JP 2001057895 A JP2001057895 A JP 2001057895A JP 11233656 A JP11233656 A JP 11233656A JP 23365699 A JP23365699 A JP 23365699A JP 2001057895 A JP2001057895 A JP 2001057895A
Authority
JP
Japan
Prior art keywords
pha
poly
hydroxyalkanoic acid
surfactant
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11233656A
Other languages
Japanese (ja)
Other versions
JP3930668B2 (en
Inventor
Osamu Odawara
修 小田原
Kenji Miyamoto
憲二 宮本
Satoshi Yokomizo
聡 横溝
Keiji Matsumoto
圭司 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Priority to JP23365699A priority Critical patent/JP3930668B2/en
Publication of JP2001057895A publication Critical patent/JP2001057895A/en
Application granted granted Critical
Publication of JP3930668B2 publication Critical patent/JP3930668B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To efficiently extract and separate the subject compound by adding a divalent or polyvalent metal salt and a surfactant to a suspension of a microbial cell of a poly-3-hydroxyalkanoic acid-containing microorganism in an extraction solvent and flocculating and removing an undissolved cell residue. SOLUTION: A divalent or polyvalent metal salt (e.g. calcium chloride, etc.), and/or a surfactant (e.g. benzyltrimethlammonium chloride, etc.), is added to a suspension of a microbial cell of poly-3-hydroxyalkanoic acid (PHA)-containing microorganism [e.g. Aicaligenes eutrophus A32C(FERM P-15786) strain into which a PHA synthase gene derived from Aeromonas caviae is transferred, etc.], and an extraction solvent (e.g. chloroform, etc.), and undissolved cell residue is flocculated and removed from the PHA-containing solution to readily obtain a high-purity poly-3-hydroxyalkanoic acid useful as a biodegradable plastic, etc., in an improved efficiency of industrial production at a low cost.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、ポリ−3−ヒドロ
キシアルカン酸の、微生物菌体からの抽出分離方法に関
するものである。
TECHNICAL FIELD The present invention relates to a method for extracting and separating poly-3-hydroxyalkanoic acid from microbial cells.

【0002】[0002]

【従来の技術】現在、プラスチック廃棄物は焼却、埋め
立てなどにより処理されているが、これらの処理方法に
は地球の温暖化や埋め立て地の地盤弛緩等の問題点があ
る。そのためプラスチックリサイクルへの社会意識の高
まりとともに、リサイクルシステム化が進みつつある。
しかし、リサイクル可能な用途には限りがあり、実際問
題としてプラスチック廃棄処理方法としては、焼却、埋
め立て、リサイクルだけでは対応しきれず、自然界に放
置されたままになるものも多い。そこで、廃棄後は自然
界の物質循環に取り込まれ、分解生成物が有害とならな
い生分解性プラスチックが注目されており、その実用化
が切望されている。
2. Description of the Related Art At present, plastic waste is treated by incineration, landfill, and the like. However, these treatment methods have problems such as global warming and ground loosening of a landfill. For this reason, with the increasing public awareness of plastic recycling, recycling systems are being promoted.
However, recyclable applications are limited, and as a practical matter, many plastic waste treatment methods cannot be dealt with only by incineration, landfill, and recycling, and are often left in the natural world. Therefore, biodegradable plastics which are taken into the material cycle in the natural world after disposal and whose decomposition products do not become harmful have been attracting attention, and their practical use has been eagerly sought.

【0003】これら生分解プラスチックの中でも、ポリ
−3−ヒドロキシアルカン酸(以後PHAと称す)は多
くの微生物種の菌体内にエネルギー蓄積物質として生
成、蓄積される生分解性を有する熱可塑性ポリエステル
であり、自然界の炭素循環プロセスに取り込まれること
から生態系への悪影響がほとんどないと予想されている
ために、特に注目されている。また、医療分野において
も、回収不要のインプラント材料、薬物担体としての利
用が可能であると考えられている。
[0003] Among these biodegradable plastics, poly-3-hydroxyalkanoic acid (hereinafter referred to as PHA) is a biodegradable thermoplastic polyester that is produced and accumulated as an energy storage substance in the cells of many microbial species. It is of particular interest because it is expected to have little adverse effect on ecosystems due to its inclusion in the natural carbon cycle process. Also, in the medical field, it is considered that it can be used as an implant material or a drug carrier that does not require collection.

【0004】微生物によって生成されたPHAは、顆粒
体を形成して菌体内に蓄積されており、これらをプラス
チックとして利用するためには、微生物の菌体内から分
離して取り出す必要がある。PHAを微生物菌体から分
離精製する既知の方法として、大別すると、PHAが可
溶である有機溶剤にPHAを溶解させて抽出する方法
と、PHA以外の菌体構成成分を可溶化させて除くこと
によりPHAを得る方法とがある。
[0004] PHA produced by microorganisms forms granules and accumulates in the cells, and in order to utilize them as plastic, it is necessary to separate them from the cells of the microorganisms. Known methods for separating and purifying PHA from microbial cells are roughly classified into a method in which PHA is dissolved and extracted in an organic solvent in which PHA is soluble, and a method in which cell components other than PHA are solubilized and removed. To obtain a PHA.

【0005】有機溶媒を用いたPHAの抽出分離方法と
しては、例えば1,2−ジクロロエタンやクロロホルム
といった疎水性のハロゲン含有炭化水素を抽出溶媒とし
て用いる方法(特開昭55−118394号、特開昭5
7−65193号)、また、ジオキサン(特開昭63−
198991号)またはプロパンジオール(特開平02
−69187号)またはテトラヒドロフラン(特開平0
7−79788号)の様な親水性の抽出溶媒を用いた方
法が提案されている。しかし、これらの方法においては
PHAを実用に値する濃度まで溶解しようとすると、そ
の抽出液は極めて粘重となり、抽出溶媒に溶解しなかっ
た菌体残査とPHAを含む溶媒層との分離が非常に困難
であるという欠点を有している。
As a method of extracting and separating PHA using an organic solvent, a method using a hydrophobic halogen-containing hydrocarbon such as 1,2-dichloroethane or chloroform as an extraction solvent (JP-A-55-118394, JP-A-55-118394, 5
7-65193) and dioxane (Japanese Unexamined Patent Publication No.
198991) or propanediol (Japanese Unexamined Patent Publication No.
-69187) or tetrahydrofuran (Japanese Unexamined Patent Publication No.
No. 7,797,788), a method using a hydrophilic extraction solvent has been proposed. However, in these methods, when attempting to dissolve PHA to a practically usable concentration, the extract becomes extremely viscous, and it is very difficult to separate the bacterial residue remaining in the extraction solvent from the solvent layer containing PHA. It is disadvantageous in that it is difficult.

【0006】一方、PHA以外の菌体構成成分を可溶化
させて除くことによりPHAを得る方法もいくつか提案
されているが(J. Gen. Microbiolo
gy,19,198−209頁(1958)、特公平0
4−61638号、特表平08−502415号、特開
平07−177894号)、PHAの著しい低分子化が
起こったり、得られるPHAの純度が低い等の問題点を
有する上に、処理工程が多く複雑であったり、毒性の高
い薬品を必要とする、あるいはコストが極めて高くなる
など、いずれも、実用には適さない方法であるのが現状
である。
On the other hand, some methods have been proposed to obtain PHA by solubilizing and removing bacterial components other than PHA (J. Gen. Microbiolo).
gy, 19, pp. 198-209 (1958), Tokuho 0
4-61638, JP-T-08-502415, JP-A-07-177894), there are problems such as the remarkable reduction of the molecular weight of PHA, and the purity of the obtained PHA is low. At present, any of these methods are not suitable for practical use, for example, they are complicated, require highly toxic chemicals, or are extremely expensive.

【0007】[0007]

【発明が解決しようとする課題】本発明の目的は、微生
物菌体からのPHAの抽出において、抽出溶媒に溶解し
なかった菌体残査とPHAを含む溶媒層とを効率よく分
離する方法を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a method for efficiently separating a PHA-containing solvent layer from a bacterial residue that has not been dissolved in an extraction solvent in the extraction of PHA from microbial cells. To provide.

【0008】[0008]

【課題を解決するための手段】本発明者らは、PHAを
工業的有利に生産できる方法について鋭意検討した結
果、PHAを含有する微生物菌体と抽出溶媒の懸濁液
に、2価以上の金属塩、または界面活性剤を添加するこ
とにより、抽出液に溶解しなかった細胞残査を凝集さ
せ、効率よく分離除去できることを見いだし、本発明に
到達した。
Means for Solving the Problems The present inventors have conducted intensive studies on a method capable of industrially producing PHA, and as a result, have found that a suspension of microbial cells containing PHA and an extraction solvent has a bivalent or higher valence. It has been found that by adding a metal salt or a surfactant, cell residues not dissolved in the extract can be aggregated and efficiently separated and removed, and the present invention has been achieved.

【0009】即ち、本発明は、PHAを含有する微生物
菌体と抽出溶媒の懸濁液に、2価以上の金属塩および/
または界面活性剤を添加して、PHAを含む溶液から未
溶解細胞残査を凝集させて除去することを特徴とするP
HAの抽出分離方法に関する。
That is, the present invention relates to a method for preparing a suspension of a microbial cell containing PHA and an extraction solvent in a suspension of a divalent or higher valent metal salt.
Alternatively, a surfactant is added to aggregate and remove undissolved cell residues from the solution containing PHA.
The present invention relates to a method for extracting and separating HA.

【0010】好ましい実施態様としては、界面活性剤が
陽イオン性である上記抽出分離方法に関する。
[0010] In a preferred embodiment, the present invention relates to the above extraction separation method wherein the surfactant is cationic.

【0011】別の好ましい実施態様としては、PHAを
含有する微生物が、アエロモナス・キャビエ由来のPH
A合成酵素群遺伝子が導入された菌株である上記抽出分
離方法に関する。
[0011] In another preferred embodiment, the microorganism containing PHA is a microorganism derived from Aeromonas caviae.
The present invention relates to the above-mentioned extraction / separation method, which is a strain into which the A synthase group gene has been introduced.

【0012】更に別の好ましい実施態様としては、PH
Aが、3HBと3HHとの2成分共重合体、または、3
HBと3HVと3HHとの3成分共重合体である上記抽
出分離方法に関する。
In still another preferred embodiment, PH
A is a two-component copolymer of 3HB and 3HH, or 3
The present invention relates to the above extraction and separation method, which is a ternary copolymer of HB, 3HV and 3HH.

【0013】[0013]

【発明の実施の形態】本発明に用いる微生物は、細胞内
にPHAを蓄積している微生物であれば特に限定されな
い。例えば、アルカリゲネス・リポリチカ(Aical
igeneslipolytica)、アルカリゲネス
・ユウトロファス(Aicaligenes eutr
ophus)、アルカリゲネス・ラタス(Aicali
genes latas)等のアルカリゲネス属(Al
caligenes)、シュウドモナス属(Pseud
omonas)、バチルス属(Bacillus)、ア
ゾトバクター属(Azotobacter)、ノカルデ
ィア属(Nocardia)、アエロモナス属(Aer
omonas)の菌が挙げられ、中でも、アロエモナス
・キャビエ(Aeromonas caviae)等の
菌株、または、アエロモナス・キャビエ由来のPHA合
成酵素群の遺伝子が導入された菌株、例えば、アルカリ
ゲネス・ユウトロファスA32C(寄託番号FERM
P−15786)等がより好ましい。
BEST MODE FOR CARRYING OUT THE INVENTION The microorganism used in the present invention is not particularly limited as long as it is a microorganism accumulating PHA in cells. For example, Alcaligenes lipolytica (Aical
geneneslipolytica), Alcaligenes eutrophus (Aicaligenes eutr)
opus), Alcaligenes latus (Aicali)
genus latas, etc. (Al)
caligenes), Pseudomonas (Pseud)
omonas), the genus Bacillus, the genus Azotobacter, the genus Nocardia, the genus Aeromonas (Aer)
(Amonas caviae), or a strain into which a gene of the PHA synthase group derived from Aeromonas caviae has been introduced, such as Alcaligenes yutrophus A32C (Accession No. FERM).
P-15786) and the like are more preferred.

【0014】これらの微生物の培養方法は、PHAを多
量に効率よく菌体内に蓄積できるものであれば特に限定
はなく、例えば、前記アルカリゲネス・ユウトロファス
A32C(FERM P−15786)を用いる場合に
は、J.Bacteriol.,179,4821−4
880頁(1997)等に記載の方法が好ましい。
The method of culturing these microorganisms is not particularly limited as long as PHA can be efficiently accumulated in a large amount in the cells. For example, when the above-mentioned Alcaligenes eutrophus A32C (FERM P-15786) is used, J. Bacteriol. , 179, 4821-4
The method described on page 880 (1997) is preferred.

【0015】本発明におけるポリ−3−ヒドロキシアル
カン酸(PHA)とは、特に限定されないが、D−3−
ヒドロキシブチレート(3HB)のホモポリマーや3H
Bと他の3−ヒドロキシアルカン酸との共重合体が好ま
しく、更には、3HBとD−3−ヒドロキシヘキサノエ
ート(3HH)との2成分共重合体(Macromol
ecules,28,4822−4828(199
5))または、3HBとD−3−ヒドロキシバレレート
(3HV)と3HHとの3成分共重合体(特開平08−
289797号)などが、物性の面からより好ましい。
ここで、3HBと3HHの2成分共重合体を構成する各
モノマーユニットの組成比については特に限定されるも
のではないが、3HBユニットの含有量が1〜99モル
%といった組成比のものが好適である。また、3HBと
3HVと3HHとの3成分共重合体を構成する各モノマ
ーユニットの組成比については特に限定されるものでは
ないが、例えば、3HBユニット含有量が1〜95モル
%、3HVユニット含有量が1〜96モル%、3HHユ
ニット含有量が1〜30モル%といった組成比のものが
好適である。またこれらPHAの分子量は10万以上が
好ましく、50万以上がより好ましい。
[0015] The poly-3-hydroxyalkanoic acid (PHA) in the present invention is not particularly limited.
Hydroxybutyrate (3HB) homopolymer and 3H
A copolymer of B and another 3-hydroxyalkanoic acid is preferable, and a two-component copolymer of 3HB and D-3-hydroxyhexanoate (3HH) (Macromol
ecules, 28, 4822-4828 (199
5)) or a ternary copolymer of 3HB, D-3-hydroxyvalerate (3HV) and 3HH (Japanese Unexamined Patent Publication No.
No. 289797) is more preferable from the viewpoint of physical properties.
Here, the composition ratio of each monomer unit constituting the two-component copolymer of 3HB and 3HH is not particularly limited, but a composition ratio in which the content of the 3HB unit is 1 to 99 mol% is preferable. It is. Further, the composition ratio of each monomer unit constituting the three-component copolymer of 3HB, 3HV and 3HH is not particularly limited. For example, the content of the 3HV unit is 1 to 95 mol%, and the content of the 3HV unit is 3%. Those having a composition ratio of 1 to 96 mol% and a 3HH unit content of 1 to 30 mol% are preferred. The molecular weight of these PHA is preferably 100,000 or more, more preferably 500,000 or more.

【0016】PHAの微生物菌体中の含有率は、高い方
が好ましいのは当然であり、工業レベルでの適用におい
ては乾燥菌体中に20重量%以上が好ましく、抽出操
作、分離操作、分離ポリマーの純度等を考慮すると50
重量%以上が特に好ましい。本発明においては、前記の
ようにして培養して得られた微生物菌体を、培養液から
分離した湿菌体としてそのまま用いても良いし、または
湿菌体を凍結乾燥機等で乾燥処理して乾燥菌体として用
いても良い。さらには、ミルや高圧ホモジナイザー等の
物理的破砕処理、界面活性剤、次亜塩素酸ナトリウムや
有機溶剤等の化学処理で菌体の一部を破壊し、または菌
体の一部を除去してPHAの含有量を高めたものを用い
ても良い。
It is natural that the content of PHA in the microbial cells is preferably higher, and in the application on an industrial level, it is preferably 20% by weight or more in the dry cells. Considering the polymer purity etc., 50
% By weight or more is particularly preferred. In the present invention, the microbial cells obtained by culturing as described above may be used directly as wet cells separated from the culture solution, or the wet cells may be subjected to a drying treatment with a freeze dryer or the like. And may be used as dried cells. Furthermore, a part of the cells is destroyed by a physical crushing treatment such as a mill or a high-pressure homogenizer, or a chemical treatment such as a surfactant, sodium hypochlorite or an organic solvent, or a part of the cells is removed. A material having an increased PHA content may be used.

【0017】本発明で使用するPHAの抽出溶媒として
は、PHAが溶解するものであれば特に限定されず、例
えば、クロロホルム、塩化メチレン、1,2−ジクロロ
エタン、ピリジン、1,2−プロピレンカーボネートの
ような環式カーボネート類、テトラヒドロフラン、乳酸
エチルやアセトニトリル等やこれらの溶媒の混合物、例
えばクロロホルムとメタノールの混合物やクロロホルム
とテトラヒドロフランの混合物等の混合溶媒系が挙げら
れる。
The extraction solvent of PHA used in the present invention is not particularly limited as long as PHA can be dissolved. For example, chloroform, methylene chloride, 1,2-dichloroethane, pyridine, and 1,2-propylene carbonate can be used. Such cyclic carbonates, tetrahydrofuran, ethyl lactate, acetonitrile and the like, and mixtures of these solvents, for example, a mixed solvent system such as a mixture of chloroform and methanol and a mixture of chloroform and tetrahydrofuran are exemplified.

【0018】本発明で使用する金属塩としては、2価以
上の金属イオンと、一般的な対イオンからなる金属塩で
あれば特に限定されず、例えば、金属イオンとしては、
カルシウム、マグネシウム、鉄、亜鉛、アルミニウム、
バリウム、マンガン、銅、コバルト等が挙げられ、対イ
オンとしては、塩化物イオン、硫酸イオン、リン酸イオ
ン、硝酸イオン、炭酸イオン等が挙げられ、金属塩の具
体的な例としては、塩化カルシウム、塩化マグネシウ
ム、塩化第一鉄、塩化第二鉄、塩化亜鉛、塩化バリウ
ム、塩化コバルト、塩化銅、塩化マンガン、塩化アルミ
ニウム、硫酸マグネシウム、硫酸亜鉛、炭酸カルシウ
ム、炭酸マグネシウム等が例示できる。また、本発明で
使用される界面活性剤としては、陰イオン性、陽イオン
性、両性もしくは非イオン性でも良いが、好ましくは陽
イオン性界面活性剤であり、具体的には、セチルトリメ
チルアンモニウムブロミド、ドデシルピリジニウムクロ
リド、テトラデシルアンモニウムブロミド、セチルピリ
ジニウムクロリド、トリエチルヘキシルアンモニウムブ
ロミド、4,4−トリメチレンビス(1−メチルピペリ
ヂン)、トリメチルフェニルアンモニウムブロミド、ベ
ンジルトリメチルアンモニウムクロリド、ヘキサデシル
トリメチルアンモニウムブロミド、アセタミン86(花
王株式会社製)コータミン24P(花王株式会社製)等
が挙げられる。
The metal salt used in the present invention is not particularly limited as long as it is a metal salt composed of a divalent or higher valent metal ion and a general counter ion.
Calcium, magnesium, iron, zinc, aluminum,
Barium, manganese, copper, cobalt, and the like, and counter ions include chloride ion, sulfate ion, phosphate ion, nitrate ion, carbonate ion, and the like. Specific examples of the metal salt include calcium chloride. , Magnesium chloride, ferrous chloride, ferric chloride, zinc chloride, barium chloride, cobalt chloride, copper chloride, manganese chloride, aluminum chloride, magnesium sulfate, zinc sulfate, calcium carbonate, magnesium carbonate and the like. The surfactant used in the present invention may be anionic, cationic, amphoteric or nonionic, but is preferably a cationic surfactant, and specifically, cetyltrimethylammonium. Bromide, dodecylpyridinium chloride, tetradecylammonium bromide, cetylpyridinium chloride, triethylhexylammonium bromide, 4,4-trimethylenebis (1-methylpiperidin), trimethylphenylammonium bromide, benzyltrimethylammonium chloride, hexadecyltrimethylammonium bromide, acetamine 86 (manufactured by Kao Corporation) Coatamine 24P (manufactured by Kao Corporation).

【0019】本発明で使用する金属塩や界面活性剤の添
加量は特に制限されないが、微生物菌体懸濁液1Lあた
り0.001〜10重量%の範囲の濃度となるように添
加するのが好ましく、さらには、0.01〜5重量%の
範囲の濃度がより好ましい。0.001重量%以下の濃
度では効果が低く、10重量%を超える濃度の場合、コ
ストの面から好ましくない。
The amount of the metal salt or surfactant used in the present invention is not particularly limited, but it is preferable to add the metal salt or the surfactant in a concentration within the range of 0.001 to 10% by weight per 1 L of the microbial cell suspension. More preferably, a concentration in the range of 0.01 to 5% by weight is more preferable. When the concentration is less than 0.001% by weight, the effect is low, and when the concentration exceeds 10% by weight, it is not preferable in terms of cost.

【0020】本発明においては、上記金属塩と界面活性
剤をいずれか単独で使用しても良いし、併用しても良
い。金属塩や界面活性剤の投入方法は、液体や固体のま
ま菌体懸濁液に投入し溶解させても良いし、あらかじめ
溶液としたのち菌体懸濁液に投入しても良い。金属塩や
界面活性剤の投入に際しては菌体懸濁液内での金属塩や
界面活性剤の分散を促進させるために菌体懸濁液を攪拌
したほうが好ましい。微生物菌体の未溶解細胞残渣を凝
集させるための攪拌時間、攪拌温度については適宜設定
できる。
In the present invention, the metal salt and the surfactant may be used alone or in combination. The metal salt or the surfactant may be charged into the cell suspension as a liquid or a solid and dissolved therein, or may be prepared as a solution and then charged into the cell suspension. When charging the metal salt or the surfactant, it is preferable to stir the cell suspension in order to promote the dispersion of the metal salt or the surfactant in the cell suspension. The stirring time and the stirring temperature for aggregating the undissolved cell residue of the microbial cells can be appropriately set.

【0021】本発明においては、PHAを含有する微生
物菌体と抽出溶媒との懸濁液に、上記のように金属塩や
界面活性剤を添加処理することで、懸濁液中の未溶解細
胞残渣が凝集するために、PHA溶液を容易に分離する
ことが出来る。ここで利用できる分離操作は、特に限定
されないが、例えば、ろ過、デカンテーション、遠心分
離機や膜分離などを一般に知られている方法が利用でき
る。ろ過による分離操作については一般に用いられるろ
材、具体的にはろ紙、ろ布、網(メッシュ)、多孔性セ
ラミック、多孔性金属板、多孔性フィルムなどが利用で
きる。デカンテーションによる分離操作としては例え
ば、微生物懸濁液を攪拌後、5分から2時間、好ましくは
10分から1時間静置し、適当な方法、たとえば吸引機
などで懸濁液上部の澄んだ溶液を回収すればよい。遠心
分離器による分離操作については一般に知られている条
件を利用でき、遠心分離器は回分式、連続式どちらでも
利用できる。
In the present invention, a suspension of a microbial cell containing PHA and an extraction solvent is treated with a metal salt or a surfactant as described above, so that undissolved cells in the suspension are treated. Since the residue aggregates, the PHA solution can be easily separated. The separation operation that can be used here is not particularly limited. For example, generally known methods such as filtration, decantation, centrifugal separation, and membrane separation can be used. For the separation operation by filtration, generally used filter media, specifically, filter paper, filter cloth, mesh (mesh), porous ceramic, porous metal plate, porous film, and the like can be used. As a separation operation by decantation, for example, after stirring the microorganism suspension, the suspension is allowed to stand for 5 minutes to 2 hours, preferably 10 minutes to 1 hour, and the clear solution at the top of the suspension is removed by an appropriate method such as a suction device. You only have to collect it. For the separation operation using a centrifuge, generally known conditions can be used, and the centrifuge can be used in either a batch type or a continuous type.

【0022】この様にして未溶解細胞残渣と分離して得
られたPHA溶液のポリマー純度は非常に高く、これを
公知の方法で溶媒を除去すれば高純度のPHAを得るこ
とが出来る。もちろん目的に応じて、結晶化やその他の
精製方法を用いて更に純度を向上させることも出来る。
The polymer purity of the PHA solution obtained by separating it from the undissolved cell residue in this way is very high, and high-purity PHA can be obtained by removing the solvent by a known method. Of course, the purity can be further improved by crystallization or other purification methods according to the purpose.

【0023】[0023]

【実施例】以下実施例により本発明を説明するが、本発
明はこれらの実施例に限定されるものではない。
EXAMPLES The present invention will be described below with reference to examples, but the present invention is not limited to these examples.

【0024】(実施例1)アエロモナス・キャビエ由来
のPHA合成酵素群遺伝子を導入したアルカリゲネス・
ユウトロファス AC32(寄託番号FERM P−1
5786)株を、J.Bacteriol.,179,
4821−4830項(1997)に記載の方法で培養
し(培地:Na2HPO4・12H2O 11.3g、KH2PO4 1.9g、(NH4)2
SO4 6g、プロエキス(播州調味料(株)製 10g、MgSO4
7H2O 1g、ヤシ油 50g、微量金属元素溶液(組成:FeCl2
・6H2O 16.2g、CaCl2・2H2O 10.3g、CoCl2・6H2O 0.2g、Ni
Cl3・6H2O 0.1g、CrCl3・6H2O 16.2g、CuSO4・5H2O 0.2g /
1L 0.1N-HCl)5ml / 1L、pH6.7、培養温度30℃、
培養時間72時間)、3HBと3HHとの2成分共重合体
(3HBユニット:3HHユニット=90:10(モル
比)、分子量 約100万)を約50重量%含有した菌
体を得た。これを遠心分離処理(5000rpm、10
min)して培養液から分離し、湿菌体とした。この湿
菌体を凍結乾燥し、乾燥菌体としたのちに、乾燥菌体で
50g/lとなるようにクロロホルムに懸濁し、室温で
5時間攪拌を行って3HBと3HHとの2成分共重合体
の抽出を行った。この微生物菌体を含む抽出液に、陽イ
オン界面活性剤であるベンジルトリメチルアンモニウム
クロリドを10g/lとなるように加えて更に1時間攪
拌し未溶解細胞残査を凝集させ、これをろ紙(桐山製作
所製、No.4)を用いて桐山ロートにて吸引ろ過し、
凝集菌体残査を分離除去した。この時目詰まりすること
なくろ過を行うことが出来た。得られた濾液に、攪拌し
ながらメタノールを加えて3HBと3HHとの2成分共
重合体の結晶を析出させ、該結晶をろ過により集め減圧
下に乾燥した。得られた3HBと3HHとの2成分共重
合体の回収率を計算したところ、98%であった。
(Example 1) Alkagenes gene into which a PHA synthase group gene derived from Aeromonas caviae was introduced.
Eutrofus AC32 (Deposit No. FERM P-1
5786). Bacteriol. , 179,
Were cultured by the method described in Section 4821-4830 (1997) (Medium: Na 2 HPO 4 · 12H 2 O 11.3g, KH 2 PO 4 1.9g, (NH 4) 2
SO 4 6g, professional extract (Banshu Seasoning Co., Ltd. 10g, MgSO 4
7H 2 O 1g, coconut oil 50g, trace metal element solution (composition: FeCl 2
· 6H 2 O 16.2g, CaCl 2 · 2H 2 O 10.3g, CoCl 2 · 6H 2 O 0.2g, Ni
Cl 3 · 6H 2 O 0.1g, CrCl 3 · 6H 2 O 16.2g, CuSO 4 · 5H 2 O 0.2g /
1L 0.1N-HCl) 5ml / 1L, pH 6.7, culture temperature 30 ℃,
A bacterium containing about 50% by weight of a two-component copolymer of 3HB and 3HH (3HB unit: 3HH unit = 90: 10 (molar ratio), molecular weight about 1,000,000) was obtained. This is centrifuged (5000 rpm, 10
min) and separated from the culture solution to obtain wet cells. The wet cells were freeze-dried to obtain dried cells, suspended in chloroform at 50 g / l with the dried cells, and stirred at room temperature for 5 hours to obtain a two-component copolymer of 3HB and 3HH. The union was extracted. To the extract containing the microbial cells, benzyltrimethylammonium chloride as a cationic surfactant was added at a concentration of 10 g / l, and the mixture was further stirred for 1 hour to coagulate the undissolved cell residue. Suction filtration with a Kiriyama funnel using No. 4)
Aggregated cell residue was separated and removed. At this time, filtration could be performed without clogging. Methanol was added to the obtained filtrate with stirring to precipitate crystals of a binary copolymer of 3HB and 3HH, and the crystals were collected by filtration and dried under reduced pressure. The calculated recovery of the two-component copolymer of 3HB and 3HH was 98%.

【0025】(実施例2)実施例1において、陽イオン
性界面活性剤であるベンジルトリメチルアンモニウムク
ロリドをヘキサデシルトリメチルアンモニウムブロミド
に変更した以外は同様の操作を行った。得られた3HB
と3HHとの2成分共重合体の回収率は96%であっ
た。
Example 2 The same operation was performed as in Example 1, except that benzyltrimethylammonium chloride, which was a cationic surfactant, was changed to hexadecyltrimethylammonium bromide. 3HB obtained
The recovery of the two-component copolymer of and 3HH was 96%.

【0026】(実施例3)実施例1において、抽出溶媒
をクロロホルムからテトラヒドロフランに変更した以外
は同様の操作を行った。得られた3HBと3HHとの2
成分共重合体の回収率は87%であった。
Example 3 The same operation as in Example 1 was performed except that the extraction solvent was changed from chloroform to tetrahydrofuran. 2 of the obtained 3HB and 3HH
The recovery of the component copolymer was 87%.

【0027】(実施例4)実施例1で得られた湿菌体
を、乾燥することなく50g/lとなるようにテトラヒ
ドロフランに懸濁し、加熱還流下で5時間攪拌を行って
3HBと3HHとの2成分共重合体の抽出を行った。こ
の微生物菌体を含む抽出液に、塩化カルシウムを10g
/lとなるように加えて更に1時間攪拌し未溶解細胞残
査を凝集させ、これをろ紙(桐山製作所製、No.4)
を用いて桐山ロートにて吸引ろ過し、凝集菌体残査を分
離除去した。この時目詰まりすることなくろ過を行うこ
とが出来た。得られた濾液を、攪拌しながら室温まで冷
却し、3HBと3HHとの2成分共重合体の結晶を析出
させ、該結晶をろ過により集め減圧下に乾燥した。得ら
れた3HBと3HHとの2成分共重合体の回収率は80
%であった。
Example 4 The wet cells obtained in Example 1 were suspended in tetrahydrofuran at 50 g / l without drying, and the suspension was stirred for 5 hours under reflux with heating to obtain 3HB and 3HH. Was extracted. 10 g of calcium chloride was added to the extract containing the microbial cells.
/ L and further stirred for 1 hour to aggregate the undissolved cell residue, which is then filtered with filter paper (Kiriyama Seisakusho, No. 4).
The mixture was subjected to suction filtration using a Kiriyama funnel to separate and remove aggregated cell residue. At this time, filtration could be performed without clogging. The obtained filtrate was cooled to room temperature with stirring to precipitate crystals of a binary copolymer of 3HB and 3HH. The crystals were collected by filtration and dried under reduced pressure. The recovery of the obtained two-component copolymer of 3HB and 3HH is 80.
%Met.

【0028】(実施例5)実施例4において、塩化カル
シウムをベンジルトリメチルアンモニウムクロリドに変
更した以外は同様の操作を行った。得られた3HBと3
HHとの2成分共重合体の回収率は83%であった。
Example 5 The same operation as in Example 4 was performed except that calcium chloride was changed to benzyltrimethylammonium chloride. 3HB and 3 obtained
The recovery of the two-component copolymer with HH was 83%.

【0029】(実施例6)アルカリゲネス・ユウトロフ
ァス(ATCC17699)株を、グルコースを炭素源
として培養し(培地:グルコース 20g、Na2HPO4・12H2O
9g、KH2PO4 1.5g、(NH4)2SO4 6g、MgSO4・7H2O 0.2g、
微量金属元素溶液(組成:FeCl2・6H2O 16.2g、CaCl2・2H
2O 10.3g、CoCl2・6H2O 0.2g、NiCl3・6H2O 0.1g、CrCl3
6H2O 16.2g、CuSO4・5H2O 0.2g / 1L 0.1N-HCl)5ml / 1
L、pH6.8、培養温度30℃、培養時間48時間)、
3HBのホモポリマー(3HBユニット 100%)を菌
体内に約60重量%含有した菌体を得た。これを遠心分
離処理(5000rpm、10min)して培養液から
分離し、湿菌体とした。この湿菌体を凍結乾燥し、乾燥
菌体としたのちに、乾燥菌体で50g/lとなるように
クロロホルムに懸濁し、室温で5時間攪拌を行って3H
Bホモポリマーの抽出を行った。この微生物菌体を含む
抽出液に、陽イオン性界面活性剤であるベンジルトリメ
チルアンモニウムクロリドを10g/lとなるように加
えて更に1時間攪拌しクロロホルムに溶解しない細胞残
査を凝集させ、これをろ紙(桐山製作所製、No.4)
を用いて桐山ロートにて吸引ろ過し、凝集菌体残査を分
離除去した。この時目詰まりすることなく、ろ過を行う
ことが出来た。得られた濾液に、攪拌しながらメタノー
ルを加えて3HBホモポリマーの結晶を析出させ、該結
晶をろ過により集め減圧下に乾燥した。得られた3HB
ホモポリマーの回収率を計算したところ、95%であっ
た。
Example 6 Alcaligenes eutrophus (ATCC 17699) strain was cultured using glucose as a carbon source (medium: glucose 20 g, Na 2 HPO 4 .12H 2 O).
9g, KH 2 PO 4 1.5g, (NH 4) 2 SO 4 6g, MgSO 4 · 7H 2 O 0.2g,
Trace metal element solution (Composition: 16.2 g of FeCl 2 .6H 2 O, CaCl 2 .2H
2 O 10.3 g, CoCl 2 .6H 2 O 0.2 g, NiCl 3 .6H 2 O 0.1 g, CrCl 3.
6H 2 O 16.2g, CuSO 4 · 5H 2 O 0.2g / 1L 0.1N-HCl) 5ml / 1
L, pH 6.8, culture temperature 30 ° C, culture time 48 hours),
Cells containing about 60% by weight of 3HB homopolymer (3HB unit 100%) in the cells were obtained. This was centrifuged (5000 rpm, 10 min) and separated from the culture solution to obtain wet cells. The wet cells were freeze-dried to obtain dried cells, suspended in chloroform at 50 g / l with the dried cells, and stirred at room temperature for 5 hours to give 3H.
Extraction of B homopolymer was performed. To the extract containing the microbial cells, benzyltrimethylammonium chloride, a cationic surfactant, was added to a concentration of 10 g / l, and the mixture was further stirred for 1 hour to aggregate cell residues that were not dissolved in chloroform. Filter paper (Kiriyama Seisakusho, No. 4)
The mixture was subjected to suction filtration using a Kiriyama funnel to separate and remove aggregated cell residue. At this time, filtration could be performed without clogging. Methanol was added to the obtained filtrate while stirring to precipitate 3HB homopolymer crystals, and the crystals were collected by filtration and dried under reduced pressure. 3HB obtained
The calculated recovery of the homopolymer was 95%.

【0030】(実施例7)実施例6において、陽イオン
性界面活性剤であるベンジルトリメチルアンモニウムク
ロリドをヘキサデシルトリメチルアンモニウムブロミド
に変更した以外は同様の操作を行った。得られた3HB
ホモポリマーの回収率は94%であった。
Example 7 A similar operation was performed as in Example 6, except that benzyltrimethylammonium chloride, which was a cationic surfactant, was changed to hexadecyltrimethylammonium bromide. 3HB obtained
The recovery of the homopolymer was 94%.

【0031】(実施例8)実施例6において、抽出溶媒
をクロロホルムからテトラヒドロフランに変更した以外
は同様の操作を行った。得られた3HBホモポリマーの
回収率は85%であった。
Example 8 The same operation as in Example 6 was performed except that the extraction solvent was changed from chloroform to tetrahydrofuran. The recovery of the obtained 3HB homopolymer was 85%.

【0032】(実施例9)実施例6で得られた湿菌体
を、乾燥することなく50g/lとなるようにテトラヒ
ドロフランに懸濁し、加熱還流下で5時間攪拌を行って
3HBホモポリマーの抽出を行った。この微生物菌体を
含む抽出液に、塩化カルシウムを10g/lとなるよう
に加えて更に1時間攪拌し未溶解細胞残査を凝集させ、
これをろ紙(桐山製作所製、No.4)を用いて桐山ロ
ートにて吸引ろ過し、凝集菌体残査を分離除去した。こ
の時目詰まりすることなくろ過を行うことが出来た。得
られた濾液を、攪拌しながら室温まで冷却し、3HBホ
モポリマーの結晶を析出させ、該結晶をろ過により集め
減圧下に乾燥した。得られた3HBホモポリマーの回収
率は81%であった。
Example 9 The wet cells obtained in Example 6 were suspended in tetrahydrofuran at 50 g / l without drying and stirred for 5 hours under reflux with heating to obtain a 3HB homopolymer. An extraction was performed. Calcium chloride was added to the extract containing the microbial cells at a concentration of 10 g / l, and the mixture was further stirred for 1 hour to aggregate undissolved cell residues.
This was subjected to suction filtration using a filter paper (manufactured by Kiriyama Seisakusho, No. 4) with a Kiriyama funnel to separate and remove flocculent cell residue. At this time, filtration could be performed without clogging. The obtained filtrate was cooled to room temperature with stirring to precipitate crystals of 3HB homopolymer, and the crystals were collected by filtration and dried under reduced pressure. The recovery of the obtained 3HB homopolymer was 81%.

【0033】(実施例10)実施例9において、塩化カ
ルシウムを陽イオン性界面活性剤であるベンジルトリメ
チルアンモニウムクロリドに変更した以外は同様の操作
を行った。得られた3HBホモポリマーの回収率は83
%であった。
Example 10 The same operation as in Example 9 was carried out except that calcium chloride was changed to benzyltrimethylammonium chloride as a cationic surfactant. The recovery of the obtained 3HB homopolymer was 83
%Met.

【0034】(実施例11)実施例1において、アルカ
リゲネス・ユウトロファス AC32(FERMP−1
5786)をアエロモナス・キャビエ FA440(寄
託番号FERMBP−3432)に変更した以外は同様
の条件で培養し、3HBと3HHとの2成分共重合体
(3HBユニット:3HHユニット=10:90(モル
比))を約30重量%含有した菌体を得た。これを遠心
分離処理(5000rpm、10min)して培養液か
ら分離し、湿菌体とした。この湿菌体を凍結乾燥し、乾
燥菌体としたのちに、乾燥菌体で50g/lとなるよう
にクロロホルムに懸濁し、室温で5時間攪拌を行って3
HBと3HHとの2成分共重合体の抽出を行った。この
微生物菌体を含む抽出液に、陽イオン界面活性剤である
ベンジルトリメチルアンモニウムクロリドを10g/l
となるように加えて更に1時間攪拌し未溶解細胞残査を
凝集させ、これをろ紙(桐山製作所製、No.4)を用
いて桐山ロートにて吸引ろ過し、凝集菌体残査を分離除
去した。この時目詰まりすることなくろ過を行うことが
出来た。得られた濾液に、攪拌しながらメタノールを加
えて3HBと3HHとの2成分共重合体の結晶を析出さ
せ、該結晶をろ過により集め減圧下に乾燥した。得られ
た3HBと3HHとの2成分共重合体の回収率を計算し
たところ、96%であった。
(Example 11) In Example 1, Alcaligenes eutrophus AC32 (FERMP-1) was used.
5786) was changed to Aeromonas caviae FA440 (Accession No. FERMBP-3432), and cultured under the same conditions, and a two-component copolymer of 3HB and 3HH (3HB unit: 3HH unit = 10: 90 (molar ratio)) ) Was obtained at about 30% by weight. This was centrifuged (5000 rpm, 10 min) and separated from the culture solution to obtain wet cells. The wet cells were freeze-dried to obtain dried cells, suspended in chloroform at 50 g / l with the dried cells, and stirred at room temperature for 5 hours.
Extraction of a two-component copolymer of HB and 3HH was performed. 10 g / l of benzyltrimethylammonium chloride, a cationic surfactant, was added to the extract containing the microbial cells.
The mixture was further stirred for 1 hour to aggregate the undissolved cell residue, and this was filtered with a Kiriyama funnel using a filter paper (manufactured by Kiriyama Seisakusho, No. 4) to separate the aggregated cell residue. Removed. At this time, filtration could be performed without clogging. Methanol was added to the obtained filtrate with stirring to precipitate crystals of a binary copolymer of 3HB and 3HH, and the crystals were collected by filtration and dried under reduced pressure. The calculated recovery of the obtained two-component copolymer of 3HB and 3HH was 96%.

【0035】(比較例1)実施例1において、ベンジル
トリメチルアンモニウムクロライドを添加しなかった以
外は同様の操作を行った。ろ過の段階で目詰まりが激し
く菌体残渣を分離することができなかった。
Comparative Example 1 The same operation as in Example 1 was performed except that benzyltrimethylammonium chloride was not added. At the stage of filtration, clogging was so severe that cell residue could not be separated.

【0036】(比較例2)実施例6において、ベンジル
トリメチルアンモニウムクロリドを添加しなかった以外
は同様の操作を行った。その結果、ろ過の段階で目詰ま
りが激しく菌体残渣を分離することができなかった。
Comparative Example 2 The same operation as in Example 6 was carried out except that benzyltrimethylammonium chloride was not added. As a result, clogging was so severe at the filtration stage that bacterial cell residues could not be separated.

【0037】[0037]

【発明の効果】本発明によれば、PHAを含有する微生
物菌体と抽出溶媒との懸濁液に、2価以上の金属塩や界
面活性剤を添加するという極めて簡便な操作によって、
未溶解細胞残査を凝集させて除去することが可能とな
り、容易に高純度のPHAが得られるため、本発明は、
微生物によるPHAの工業的生産の効率向上およびコス
トの低減に大きく寄与するものである。
According to the present invention, a very simple operation of adding a divalent or higher-valent metal salt or a surfactant to a suspension of a microbial cell containing PHA and an extraction solvent is achieved.
The present invention makes it possible to aggregate and remove undissolved cell residues and easily obtain high-purity PHA.
It greatly contributes to improving the efficiency of industrial production of PHA by microorganisms and reducing costs.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 ポリ−3−ヒドロキシアルカン酸を含有
する微生物菌体と抽出溶媒の懸濁液に、2価以上の金属
塩および/または界面活性剤を添加して、ポリ−3−ヒ
ドロキシアルカン酸を含む溶液から未溶解細胞残査を凝
集させて除去することを特徴とするポリ−3−ヒドロキ
シアルカン酸の抽出分離方法。
1. A poly-3-hydroxyalkane obtained by adding a divalent or higher valent metal salt and / or a surfactant to a suspension of microbial cells containing poly-3-hydroxyalkanoic acid and an extraction solvent. A method for extracting and separating poly-3-hydroxyalkanoic acid, comprising agglutinating and removing undissolved cell residues from a solution containing an acid.
【請求項2】 界面活性剤が陽イオン性である請求項1
記載のポリ−3−ヒドロキシアルカン酸の抽出分離方
法。
2. The method according to claim 1, wherein the surfactant is cationic.
The method for extracting and separating poly-3-hydroxyalkanoic acid according to the above.
【請求項3】 ポリ−3−ヒドロキシアルカン酸を含有
する微生物が、アエロモナス・キャビエ由来のポリ−3
−ヒドロキシアルカン酸合成酵素群遺伝子が導入された
菌株である請求項1または2記載の抽出分離方法。
3. The method according to claim 1, wherein the microorganism containing poly-3-hydroxyalkanoic acid is poly-3 derived from Aeromonas caviae.
The method according to claim 1 or 2, wherein the strain is a strain into which a gene for a hydroxyalkanoate synthase group has been introduced.
【請求項4】ポリ−3−ヒドロキシアルカン酸が、D−
3−ヒドロキシブチレート(3HB)とD−3−ヒドロ
キシヘキサノエート(3HH)との2成分共重合体、ま
たは、D−3−ヒドロキシブチレート(3HB)とD−
3−ヒドロキシバレレート(3HV)とD−3−ヒドロ
キシヘキサノエート(3HH)との3成分共重合体であ
る請求項1〜3記載の抽出分離方法。
4. The method of claim 1, wherein the poly-3-hydroxyalkanoic acid is D-
Binary copolymer of 3-hydroxybutyrate (3HB) and D-3-hydroxyhexanoate (3HH), or D-3-hydroxybutyrate (3HB) and D-
4. The extraction separation method according to claim 1, which is a three-component copolymer of 3-hydroxyvalerate (3HV) and D-3-hydroxyhexanoate (3HH).
JP23365699A 1999-08-20 1999-08-20 Method for extracting poly-3-hydroxyalkanoic acid Expired - Fee Related JP3930668B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23365699A JP3930668B2 (en) 1999-08-20 1999-08-20 Method for extracting poly-3-hydroxyalkanoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23365699A JP3930668B2 (en) 1999-08-20 1999-08-20 Method for extracting poly-3-hydroxyalkanoic acid

Publications (2)

Publication Number Publication Date
JP2001057895A true JP2001057895A (en) 2001-03-06
JP3930668B2 JP3930668B2 (en) 2007-06-13

Family

ID=16958475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23365699A Expired - Fee Related JP3930668B2 (en) 1999-08-20 1999-08-20 Method for extracting poly-3-hydroxyalkanoic acid

Country Status (1)

Country Link
JP (1) JP3930668B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065608A1 (en) * 2003-01-20 2004-08-05 Kaneka Corporation Method of collecting highly pure polyhydroxyalkanoate from microbial cells
WO2005059153A1 (en) 2003-12-19 2005-06-30 Tianan Biologic Material Co., Ltd. Ningbo A METHOD FOR SEPARATING, EXTRACTING AND PURIFING POLY- β -HYDROXYALKANOATES (PHA’s) DIRECTLY FROM BACTERIAL FERMENTED BROTH
JP2005348640A (en) * 2004-06-09 2005-12-22 Asahi Breweries Ltd Method for purification of pha
JPWO2004041936A1 (en) * 2002-11-08 2006-03-09 株式会社カネカ Biodegradable polyester aqueous dispersion and method for producing the same
WO2018070492A1 (en) * 2016-10-13 2018-04-19 株式会社カネカ Method for producing polyhydroxyalkanoic acid

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004041936A1 (en) * 2002-11-08 2006-03-09 株式会社カネカ Biodegradable polyester aqueous dispersion and method for producing the same
JP4553733B2 (en) * 2002-11-08 2010-09-29 株式会社カネカ Biodegradable polyester aqueous dispersion and method for producing the same
WO2004065608A1 (en) * 2003-01-20 2004-08-05 Kaneka Corporation Method of collecting highly pure polyhydroxyalkanoate from microbial cells
JPWO2004065608A1 (en) * 2003-01-20 2006-05-18 株式会社カネカ Method for recovering high-purity polyhydroxyalkanoate from microbial cells
US7393668B2 (en) 2003-01-20 2008-07-01 Kaneka Corporation Method of collecting highly pure polyhydroxyalkanoate from microbial cells
WO2005059153A1 (en) 2003-12-19 2005-06-30 Tianan Biologic Material Co., Ltd. Ningbo A METHOD FOR SEPARATING, EXTRACTING AND PURIFING POLY- β -HYDROXYALKANOATES (PHA’s) DIRECTLY FROM BACTERIAL FERMENTED BROTH
JP2005348640A (en) * 2004-06-09 2005-12-22 Asahi Breweries Ltd Method for purification of pha
WO2018070492A1 (en) * 2016-10-13 2018-04-19 株式会社カネカ Method for producing polyhydroxyalkanoic acid
JPWO2018070492A1 (en) * 2016-10-13 2019-07-25 株式会社カネカ Method for producing polyhydroxyalkanoic acid
JP6993980B2 (en) 2016-10-13 2022-02-04 株式会社カネカ Method for producing polyhydroxyalkanoate

Also Published As

Publication number Publication date
JP3930668B2 (en) 2007-06-13

Similar Documents

Publication Publication Date Title
JPH09191893A (en) Production of hydroxyalkanoic acid copolymer
EP1705250B9 (en) A method for separating, extracting and purifying poly-beta-hydroxyalkanoates (phas) directly from bacterial fermented broth
US7098298B2 (en) Method for producing polyhydroxyalkanoate crystal
JP3930668B2 (en) Method for extracting poly-3-hydroxyalkanoic acid
JP3930667B2 (en) Method for separating and purifying poly-3-hydroxyalkanoic acid
JPWO2004029266A1 (en) Method for purifying 3-hydroxyalkanoic acid copolymer
JP2008054541A (en) Method for separating and purifying 3-hydroxyalkanoic acid copolymer produced by fermentation
JP6864585B2 (en) Method for producing polyhydroxy alkanoate
JPH0523189A (en) Production of polyester copolymer
JP4126511B2 (en) Method for recovering poly-3-hydroxybutyric acid from microbial cells
US7314740B2 (en) Method of separating poly-3-hydroxyalkanoic acid
JPS63198991A (en) Separation and purification of poly-beta-hydroxy lactic acid
EP1550724A1 (en) Method of coagulating poly-3-hydroxyalkanoic acid
JPH1132789A (en) Production of hydroxyalkanoic acid copolymer
JPWO2005049692A1 (en) Process for producing polyhydroxyalkanoate crystals
JP4007580B2 (en) Method and apparatus for producing polyhydroxyalkanoate
KR20010009719A (en) Method of separation polyhydroxyalkanoates from microorganism
JP2002125655A (en) Apparatus for producing polyhydroxyalkanoate
JP2009207380A (en) Method for purifying polyhydroxyalkanoic acid
JP2001340095A (en) Method for separating polyhydroxyalkanoic acid from biological cell
JPS62205787A (en) Separation and purification of poly-beta-hydroxybutyric acid
KR0145945B1 (en) Process for preparing poly-beta hydroxybutyric acid with high purity
JP2001057880A (en) Separation of microbial cell of microorganism
JPH06181784A (en) Production of copolyester
JP2000166585A (en) Separation of polymer fine particle from microorganism using functional water

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070110

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070110

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070213

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070309

R150 Certificate of patent or registration of utility model

Ref document number: 3930668

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100316

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110316

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110316

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120316

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130316

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140316

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140316

Year of fee payment: 7

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees